Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 USD | +6.69% | -6.91% | -39.40% |
Mar. 15 | AC Immune Files $350 Million Mixed Shelf | MT |
Mar. 14 | AC Immune SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 12.49M 13.79M | Sales 2025 * | 60.77M 67.11M | Capitalization | 258M 285M |
---|---|---|---|---|---|
Net income 2024 * | -62M -68.47M | Net income 2025 * | -24M -26.5M | EV / Sales 2024 * | 20.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.24 x |
P/E ratio 2024 * |
-4.3
x | P/E ratio 2025 * |
-11.8
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.21% |
1 day | +6.69% | ||
1 week | -6.91% | ||
Current month | -16.30% | ||
1 month | -20.05% | ||
3 months | -39.03% | ||
6 months | +1.00% | ||
Current year | -39.40% |
Managers | Title | Age | Since |
---|---|---|---|
Andrea Pfeifer
FOU | Founder | 66 | 03-02-12 |
Director of Finance/CFO | 35 | 18-12-31 | |
Nuno Mendonça
CTO | Chief Tech/Sci/R&D Officer | 42 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Williams
CHM | Chairman | 66 | 17-12-31 |
Carl June
BRD | Director/Board Member | 70 | 20-11-19 |
Werner Lanthaler
BRD | Director/Board Member | 56 | 18-07-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 3.03 | +6.69% | 193,211 |
24-03-26 | 2.84 | -2.07% | 984,868 |
24-03-25 | 2.9 | -5.54% | 207,722 |
24-03-22 | 3.07 | -2.54% | 260,750 |
24-03-21 | 3.15 | -3.23% | 128,159 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.40% | 285M | |
+9.16% | 45.97B | |
+54.37% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |